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Abstract
A series of novel substituted 1-benzhydryl-piperazine sulfonamide 8(a–f) and benzamides 9(a–h) were synthesized and their
antimicrobial activities evaluated in vitro by paper disc diffusion and micro dilution method against standard strains of Gram-
positive (Staphylococcus aureus ATCC 25953, Staphylococcus epidermis 25212, Bacillus cereus 11778, Bacillus substilis 6051) and
Gram-negative (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 2853, Proteus vulgaris ATCC 2853 and
Salmonella typhi ATCC 9484) bacteria. Among the synthesized new compounds 8d, 8e, 9c, 9e, 9f and 9h showed potent
antimicrobial activities compared to the standard drug streptomycin.
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Introduction
Diseases caused by microbial infection are a serious
menace to the health of human beings and often have
connection to some the other diseases (opportunistic),
whenever the body system gets debilitated. In order to
combat these diseases a number of drugs are available
in clinical practice, ranging from natural product
antibacterials to tailor-made antibacterial drugs.
Developing antimicrobial drugs and maintaining their
potency, inopposition to resistance by different classes
of microorganisms as well as a broad spectrum of
antibacterial activity are some of the major concern of
research in this area. The scaffold piperazine and its
analogues are an important pharmacophore that can be
found in biologically active compounds across a
number of different therapeutic areas [1]. These
include anticancer [2–3], antimicrobial [4], anti-
malarial, antipsychotic agents [5], HIV protease
inhibitors [6–8], antidepressants [9] and antitumor
drugs against colon, prostate, breast, lung and
leukemia cancers [10]. In 1935 Domargk showed the
therapeutic value of the sulfonamides. These sub-
stances are not specific to group of organisms, but are
effective against a large variety of pathogenic organ-
isms. Sulfonamides are among the most widely used
antibacterial agents [11] and can produce a variety of
outward effects due partly to allergy, direct toxicity,
allergic nephritis and anaemia [12]. Piperazine
sulfonamides exhibit diverse therapeutic activities
such as antibacterial activity, matrix metalloprotein-3
inhibition and carbonic anhydrase inhibition [13].
Compounds containing an amide bond with
fluorine atom substitution can alter the chemical
properties, disposition and biological activities of
drugs [14]. Amides are currently used antidepress-
ants, anti-inflammatory agents, antimalarial agents,
antipsychotic agents, antiviral agents, steroids and
general anesthetics [15]. Amide functional groups are
also found in many antibacterial agents e.g. benzimi-
dazole carboxamides, peptide, penicillin, cephalo-
sporins and thiozolidinones [16]. Recently we have
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reported the synthesis and antimicrobial activity of
bioactive heterocyclic sulfonamides and benzamides
[17–19]. In continuation of our research on the
synthesis of bioactive heterocycles and their biological
evaluation, we describe here the synthesis of 1-
benzhydryl-piperazine derivatives 8(a–f) and 9(a–h)
along with their invitro antimicrobial activity by paper
disc diffusion and micro dilution method.
Materials and methods
Chemistry
Melting points were determined using Veego model
VMP-III melting point apparatus and are uncor-
rected. Infrared (IR) spectra were recorded using a
Jasco FTIR-4100 series. Nuclear magnetic resonance
(1H NMR) spectra were recorded on a Bruker AM-
400, and chemical shifts are expressed in parts per
million (ppm, for d) relative to tetra methyl silane as an
internal standard and DMSO-d6 as solvent. Spin
multiplets are given as s (singlet), d (doublet), t
(triplet), q (quartet) and m (multiplet). Elemental
(CHNS) analysis was obtained on Vario EL III
Elementar. Silica gel column chromatography was
performed using Merck 7734 silica gel (60-120 mesh)
and Merck made TLC plates. All of the reagents and
chemicals were purchased from Sigma Aldrich
Chemicals Pvt Ltd.
1-benzhydryl-piperazine derivatives 8(a–f) and
9(a–h) were prepared by the method summarized in
Scheme 1. The reaction between benzaldehyde (1)
with phenylmagnesium bromide (2) under nitrogen
atmosphere gave benzhydrol (3). Compound 3 was
subsequently treated with thionyl chloride to give
the corresponding benzhydryl chloride (4) which was
directly treated with piperazine and anhydrous
potassium carbonate using dimethyl formamide as
a solvent at 808C gave target key intermediate
1-benzhydryl-piperazine (5). The nucleophilic
substitution reaction of 1-benzhydryl-piperazine (5)
with different substituted aromatic sulfonyl chlorides
Scheme 1. Synthesis of titled compounds.
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(R1ZSO2ZCl) and acid chlorides (R2ZCOZCl) were
carried out in presence of triethylamine and dichlor-
omethane as solvent with a good yield ranging from
65–90%. The absence of NZH proton peak in
synthesized derivatives 8(a–f) and 9(a–h) in proton
NMR and IR spectra confirms our products. It is also
confirmed by IR data, for sulfonamide series 8(a–f)
which showed asymmetric stretching frequency of
OvSvO in the range 1350Z1370 cm21 and
symmetric stretching frequency at 1270–1290 cm21
and similarly for carboxamide series 9(a–h), IR data
showed stretching frequency of ZCvO at 1630–
1670 cm21.
General procedure for synthesis of 1-benzhydryl-piperazine
derivatives 8(a–f) and 9(a–h). A solution of 1-
benzhydryl-piperazine 5 (1.0 eq) in dry dichloro-
methane was cooled to 0–58C in an ice bath.
Triethylamine (3 eq) was added to the cold reaction
mixture and stirred for 10 min then appropriate sulfonyl
chlorides (1.0 eq) or acid chloride (1.0 eq) were added
and the reaction mixture was allowed to stirr at room
temperature for 5–6 h. The progress of the reaction was
monitored by TLC. Upon completion, the solvent was
removed under reduced pressure and the residue was
taken in water and extracted with ethyl acetate. The
organic layer waswashed with 10% ammonium chloride
solution and finally water, then dried with anhydrous
sodium sulphate. The solvent was evaporated to give the
crude product which was purified by column
chromatography over silica gel (60–120mesh) using
hexane: ethyl acetate (8:2) as an eluent.
1-benzhydryl-4-(2-nitro-benzensulfonyl)-piperazine
(8a). The general synthetic method described above
afforded 8a, and the product obtained was white
crystalline solid from 1-benzhydryl-piperazine 5
(0.5 g, 1.98 mmol) and 2-nitro-benzenesulfonyl chlor-
ide 6a (0.439 g, 1.98 mmol). Yield (%): 78, M.P (8C):
160–162. 1H NMR (DMSO-d6, 400 MHz) d: 7.92–
7.99 (m, 3H, Ar-H), 7.80 (t, 1H, J ¼ 1.16 Hz, Ar-H),
7.38 (d, 4H, J ¼ 7.28 Hz, Ar-H), 7.27 (t, 4H,
J ¼ 7.36 Hz, Ar-H), 7.15 (t, 2H, J ¼ 7.24 Hz, Ar-
H), 4.35 (s, 1H,ZCH), 3.2 (br s, 4H,ZCH2Z), 2.35
(br s, 4H, ZCH2Z). IR (KBr, cm
21): 3106, 2924,
1529, 1350, 1285. Anal. calcd. for C23H23N3O4S (in
%): C-63.14, H-5.30, N-9.6, S-7.33. Found C-63.10,
H-5.25, N-9.3, S-7.29%.
1-benzhydryl-4-(3-nitro-benzensulfonyl)-piperazine
(8b). The general synthetic method described above
afforded 8b, and the product obtained was off white
crystalline solid from 1-benzhydryl-piperazine 5
(0.5 g, 1.98 mmol) and 3-nitro-benzenesulfonyl chlor-
ide 6b (0.439 g, 1.98 mmol). Yield (%): 70, M.P (8C):
173–175. 1H NMR (DMSO-d6, 400 MHz) d: 8.0
(d, 1H, J ¼ 2.0 Hz, Ar-H), 7.65–7.6 (m, 3H, Ar-H),
7.4 (d, 4H, J ¼ 7.30, Ar-H), 7.25 (t, 4H, J ¼ 7.34 Hz,
Ar-H), 7.15 (t, 2H, J ¼ 7.23 Hz, Ar-H), 4.32 (s, 1H,
ZCH), 3.30 (br s, 4H, ZCH2Z), 2.4 (br s, 4H,
ZCH2Z). IR (KBr, cm
21): 3081, 2965, 1530, 1358,
1282. Anal. calcd. for C23H23N3O4S (in %): C-63.14,
H-5.30, N-9.6, S-7.33. Found C-63.11, H-5.25, N-
9.3, S-7.28%.
1-benzhydryl-4-(4-nitro-benzensulfonyl)-piperazine
(8c). The general synthetic method described above
afforded 8c, and the product obtained was white
crystalline solid from 1-benzhydryl-piperazine 5
(0.5 g, 1.98 mmol) and 4-nitro-benzenesulfonyl chlo-
ride 6c (0.439 g, 1.98 mmol). Yield (%): 75, M.P
(8C): 217–219. 1H NMR (DMSO-d6, 400 MHz) d:
7.7–7.85 (m, 4H, Ar-H), 7.4 (d, 4H, J ¼ 7.25 Hz, Ar-
H), 7.28 (t, 4H, J ¼ 7.35 Hz, Ar-H), 7.15 (t, 2H,
J ¼ 7.23 Hz, Ar-H), 4.32 (s, 1H, ZCHZ), 3.3 (br s,
4H, ZCH2Z), 2.41 (br s, 4H, ZCH2Z). IR (KBr,
cm21): 3073, 2961, 1536, 1358, 1283. Anal. calcd.for
C23H23N3O4S (in %): C-63.14, H-5.30, N-9.6, S-
7.33. Found C-63.10, H-5.24, N-9.2, S-7.29%.
1-benzhydryl-4-(2,5-dichloro-benzensulfonyl)-pipera-
zine (8d). The general synthetic method described
above afforded 8d, and the product obtained was white
amorphous solid from 1-benzhydryl-piperazine 5
(0.5 g, 1.98 mmol) and 2,5-dichloro-benzenesulfonyl
chloride 6d (0.486 g, 1.98 mmol).Yield (%): 80, M.P
(oC): 136–138. 1H NMR (DMSO-d6, 400 MHz) d:
7.9 (d, 1H, J ¼ 2.28 Hz, Ar-H), 7.75-7.8 (m, 2H, Ar-
H), 7.4 (d, 4H, J ¼ 7.24 Hz, Ar-H), 7.25 (t, 4H,
J ¼ 7.60 Hz, Ar-H), 7.16 (t, 2H, J ¼ 7.2 Hz, Ar-H),
4.33 (s, 1H, ZCHZ), 3.25 (br s, 4H, ZCH2Z), 2.32
(br s, 4H, ZCH2Z). IR (KBr, cm
21): 2978, 2852,
1350, 1280, 752. Anal. calcd. for C23H22Cl2N2O2S (in
%): C-59.87, H-4.81, N-6.07, S-6.95. Found C-
59.82, H-4.78, N-6.04, S-6.90%.
1-benzhydryl-4-(4-chloro-benzensulfonyl)-piperazine
(8e). The general synthetic method described above
afforded 8e, and the product obtained was white
amorphous solid from 1-benzhydryl-piperazine 5
(0.5 g, 1.98 mmol) and 4-chloro-benzenesulfonyl
chloride 6e (0.418 g, 1.98 mmol). Yield (%): 76,
M.P (oC): 153–155. 1H NMR (DMSO-d6,
400 MHz) d: 7.7–7.8 (m, 4H, Ar-H), 7.4 (d, 4H,
J ¼ 7.27 Hz, Ar-H), 7.25 (t, 4H, J ¼ 7.36 Hz, Ar-H),
7.16 (t, 2H, J ¼ 7.24 Hz, Ar-H), 4.32 (s, 1H, ZCH),
3.31 (br s, 4H,ZCH2Z), 2.40 (br s, 4H,ZCH2Z). IR
(KBr, cm21): 2961, 2889, 1350, 1279, 707. Anal.
calcd.for C23H23ClN2O2S (in %): C-59.87, H-4.81,
N-6.07, S-6.95. Found C-59.82, H-4.78, N-6.04,
S-6.90%.
1-benzhydryl-4-(4-tert-butyl-benzensulfonyl)-pipera-
zine (8f). The general synthetic method described
above afforded 8f, and the product obtained was white
amorphous solid from 1-benzhydryl-piperazine5 (0.5 g,
1.98 mmol) and 4-tert-butyl-benzenesulfonyl chloride
6f (0.461 g, 1.98 mmol). Yield (%): 90, M.P (oC): 198–
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200. 1H NMR (DMSO-d6, 400 MHz) d: 7.63–7.7 (m,
4H, Ar-H), 7.35 (d, 4H, J ¼ 7.24 Hz, Ar-H), 7.26 (t,
4H, J ¼ 7.28 Hz, Ar-H), 7.16 (t, 2H, J ¼ 7.18 Hz, Ar-
H), 4.3 (s, 1H,ZCH), 2.9 (br s, 4H,ZCH2Z), 2.35 (br
s, 4H, ZCH2Z), 1.3 (s, 9H, (ZCH3)3). IR (KBr,
cm21): 3028, 2852, 1346, 1279, 1399. Anal. calcd. for
C23H32N2O2S (in %): C-72.29, H-7.19, N-6.24,
S-7.15. Found C-72.25, H-7.16, N-6.19, S-7.10%.
(4-benzhydryl-piperazin-1-yl)-(4-tert-butyl-phenyl)-
methanone (9a). The general synthetic method
described above afforded 9a, and the product obtained
was off white crystalline solid from 1-benzhydryl-
piperazine 5 (0.5 g, 1.98 mmol) and 4-tert-butyl-
benzoyl chloride 7a (0.38 g, 1.98 mmol). Yield (%):
68, M.P(oC):188–190. 1H NMR(DMSO-d6, 400MHz)
d: 7.63–7.8 (m, 4H, Ar-H), 7.36 (d, 4H, J ¼ 7.24 Hz,
Ar-H), 7.25 (t, 4H, J ¼ 7.4 Hz, Ar-H), 7.15 (t, 2H,
J ¼ 7.06 Hz, Ar-H), 4.32 (s, 1H, ZCHZ), 3.67 (br s,
2H, ZCH2), 3.24 (br s, 2H, ZCH2-), 2.34 (br s, 2H,
ZCH2Z), 2.23 (br s, 2H, ZCH2Z), 1.33 (s, 9H,
(ZCH3)3). IR (KBr, cm
21): 2961, 2857, 1634, 1394.
Anal. calcd. for C28H32N2O (in %): C-81.51, H-7.82,
N-6.79. Found C-81.47, H-7.78, N-6.74%.
(4-benzhydryl-piperazin-1-yl)-(4-chloro-phenyl)-
methanone (9b). The general synthetic method
described above afforded 9b, and the product
obtained was oily from 1-benzhydryl-piperazine 5
(0.5 g, 1.98 mmol) and 4-chloro benzoyl chloride 7b
(0.34 g, 1.98 mmol). Yield(%):70. 1H NMR (DMSO-
d6, 400 MHz) d: 7.7–7.8 (m, 4H, Ar-H), 7.4 (d, 4H,
J ¼ 7.27 Hz, Ar-H), 7.26 (t, 4H, J ¼ 7.34 Hz, Ar-H),
7.16 (t, 2H, J ¼ 7.26 Hz, Ar-H), 4.3 (s, 1H, ZCH),
3.67 (br s, 2H, ZCH2), 3.24 (br s, 2H, ZCH2), 2.34
(br s, 2H, ZCH2), 2.23 (br s, 2H, ZCH2). IR (Nujol,
cm21): 2924, 2854, 1651, 722. Anal. calcd. for
C24H23ClN2O (in %): C-73.74, H-5.93, N-7.17.
Found C-73.70, H-5.89, N-7.15%.
(4-benzhydryl-piperazin-1-yl)-(2,4-dichloro-phenyl)-
methanone (9c). The general synthetic method
described above afforded 9c, and the product
obtained was oily from 1-benzhydryl-piperazine 5
(0.5 g, 1.98 mmol) and 2,4-dichlorobenzoyl chloride
7c (0.41 g, 1.98 mmol). Yield(%): 65. 1H NMR
(DMSO-d6, 400 MHz) d: 7.68 (d, 1H, J ¼ 1.85 Hz,
Ar-H), 7.35–7.48 (m, 6H, Ar-H), 7.28 (t, 4H,
J ¼ 7.50 Hz, Ar-H), 7.18 (t, 2H, J ¼ 7.24 Hz, Ar-H),
4.34 (s, 1H,ZCH), 3.63 (br s, 2H,ZCH2Z), 3.13 (br
s, 2H,ZCH2Z), 2.37 (br s, 2H,ZCH2Z), 2.24 (br s,
2H, ZCH2Z). IR (Nujol, cm
21): 2929, 2862, 1670,
724. Anal. calcd. for C24H22Cl2N2O (in %): C-67.77,
H-5.21, N-6.59. Found C-67.73, H-5.17, N-6.55%.
(4-benzhydryl-piperazin-1-yl)-(3-bromo-phenyl)-
methanone (9d). The general synthetic method
described above afforded 9d, and the product obtained
was off white crystalline solid from 1-benzhydryl-
piperazine 5 (0.5 g, 1.98 mmol) and 3-bromo benzoyl
chloride 7d (0.43 g, 1.98 mmol). Yield (%): 80, M.P
(8C): 163–165.1H NMR (DMSO-d6, 400 MHz) d:
7.62 (m 1H, Ar-H), 7.54 (s, 1H, Ar-H), 7.43 (d, 4H,
J ¼ 7.24 Hz, Ar-H), 7.35 (m, 2H, Ar-H), 7.28 (t, 4H,
J ¼ 7.60 Hz, Ar-H), 7.17 (t, 2H, J ¼ 7.28 Hz, Ar-H),
4.32 (s, 1H,ZCH), 3.64 (br s, 2H,ZCH2Z), 3.34 (br
s, 2H, ZCH2Z), 2.31 (br s, 4H, ZCH2Z). IR (KBr,
cm21): 2935, 2842, 1670, 688. Anal. Calcd. for
C24H23BrN2O (in %): C-66.21, H-5.32, N-6.43.
Found C-66.17, H-5.28, N-6.39%.
(4-benzhydryl-piperazin-1-yl)-(2-fluoro-phenyl)-
methanone (9e). The general synthetic method
described above afforded 9e, and the product
obtained was yellowish oily from 1-benzhydryl-
piperazine 5 (0.5 g, 1.98 mmol) and 2-fluoro benzoyl
chloride 7e (0.30 g, 1.98 mmol). Yield (%): 80. 1H
NMR (DMSO-d6, 400 MHz) d: 8.0 (m, 3H, Ar-H),
7.82 (t, 1H, J ¼ 1.17 Hz, Ar-H), 7.4 (d, 4H,
J ¼ 7.27 Hz, Ar-H), 7.25 (t, 4H, J ¼ 7.35 Hz,
Ar-H), 7.15 (t, 2H, J ¼ 7.23 Hz, Ar-H), 4.3
(s, 1H, ZCH), 3.67 (br s, 2H, ZCH2Z), 3.24 (br s,
2H, ZCH2Z), 2.34 (br s, 2H, ZCH2Z), 2.23 (br s,
2H, ZCH2Z). IR (Nujol, cm
21): 3009, 2892, 1666,
1033. Anal. calcd. for C24H23FN2O (in %): C-76.98,
H-6.19, N-7.48. Found C-76.94, H-6.15, N-7.44%.
(4-benzhydryl-piperazin-1-yl)-(2,6-difluoro-phenyl)-
methanone (9f). The general synthetic method
described above afforded 9f, and the product obtained
was oily from 1-benzhydryl-piperazine 5 (0.5 g,
1.98 mmol) and 2,6-difluorobenzoyl chloride 7f
(0.34 g, 1.98 mmol). Yield (%): 77. 1H NMR (DMSO-
d6, 400 MHz) d: 7.51 (m, 1H, Ar-H), 7.43 (d, 4H,
J ¼ 7.4 Hz, Ar-H), 7.28 (t, 4H, J ¼ 7.56 Hz, Ar-H),
7.17 (t, 4H, J ¼ 6.4 Hz, Ar-H), 4.35 (s, 1H, ZCH),
3.68 (br s, 2H, ZCH2Z), 3.24 (br s, 2H, ZCH2Z),
2.36 (br s, 2H,ZCH2Z), 2.23 (br s, 2H,ZCH2Z). IR
(Nujol, cm21): 2923, 2852, 1669, 1167. Anal. calcd.
for C24H22F2N2O (in %): C-73.45, H-5.65, N-7.14.
Found C-73.40, H-5.61, N-7.09%.
(4-benzhydryl-piperazin-1-yl)-(3-methoxy-phenyl)-
methanone (9 g). The general synthetic method
described above afforded 9 g, and the product obtained
was off white crystalline solid from 1-benzhydryl-
piperazine 5 (0.5 g, 1.98 mmol) and 3-methoxybenzoyl
chloride 7 g (0.33 g, 1.98 mmol). Yield (%): 68,
M.P(8C):120–122. 1H NMR(DMSO-d6, 400 MHz)
d: 7.6 (m, 1H, Ar-H), 7.5 (s, 1H, Ar-H), 7.35 (t, 2H,
J ¼ 7.30 Hz, Ar-H), 7.3 (t, 4H, J ¼ 7.41 Hz, Ar-H),
7.25 (t, 4H, J ¼ 7.35 Hz, Ar-H), 7.15
(t, 2H, J ¼ 7.26 Hz, Ar-H), 4.3 (s, 1H, ZCH), 3.8 (s,
3H, ZOCH3Z), 3.67 (br s, 2H, ZCH2Z), 3.24 (br s,
2H, ZCH2Z), 2.34 (br s, 2H, ZCH2Z), 2.23 (br s,
2H, ZCH2Z). IR (KBr, cm
21): 3029, 2891, 1670,
1237, 1112. Anal. calcd. for C25H26N2O2 (in %): C-
77.69, H-6.78, N-7.25. Found C-77.65, H-6.74, N-
7.21%.
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(4-benzhydryl-piperazin-1-yl)-(3,5-dinitro-phenyl)-
methanone (9 h). The general synthetic method
described above afforded 9 h, and the product
obtained was white amorphous solid from 1-benz-
hydryl-piperazine 5 (0.5 g, 1.98 mmol) and 3,5-dinitro
benzoyl chloride 7h (0.45 g, 1.98 mmol). Yield (%):
64, M.P(8C): 130–132. 1H NMR(DMSO-d6, 400MHz)
d: 8.82 (bs, 1H, Ar-H), 8.57 (d, 2H, J ¼ 2.04 Hz, Ar-
H), 7.43 (d, 4H, J ¼ 7.24 Hz, Ar-H), 7.28 (t, 4H,
J ¼ 7.68 Hz, Ar-H), 7.18 (t, 2H, J ¼ 7.28 Hz, Ar-H),
4.32 (s, 1H, ZCH), 3.64 (br s, 2H, ZCH2Z), 3.24
(br s, 2H, ZCH2Z), 2.43 (br s, 2H, ZCH2Z), 2.25
(br s, 2H, ZCH2Z). IR (KBr, cm
21): 3089, 2809,
1641, 1545, 1338. Anal. calcd. for C24H22N4O5 (in %):
C-64.57, H-4.97, N-12.55. Found C-64.55, H-4.93,
N-12.51.
Microbiology: In vitro evaluation of antimicrobial activity
The standard strains were procured from the
American Type Culture Collection (ATCC) Rock-
ville, USA, and the pathological strains were procured
from the Department of Microbiology, University of
Mysore, Mysore, India. The antibacterial activity of
the synthesized compounds was screened against the
following standard Bacterial strains: Staphylococcus
aureus ATCC 25953, Staphylococcus epidermis 25212,
Bacillus cereus 11778, Bacillus substilis 6021, Escher-
ichia coli ATCC 25922, Pseudomonas aeruginosa
ATCC 2853, Proteus vulgaris ATCC 2853 and
Salmonella typhi ATCC 9484.
Paper disc diffusion method. Preliminary antibacterial
screening was performed by the agar diffusion method
using a paper disc. The sterilized (autoclaved at 1208C
for 30 min), liquified Mueller Hinton agar (40–508C)
was inoculated (1mL/100mL of medium) with the
suspension of the microorganism (matched to
McFarland Barium sulfate standard) and poured in
to a Petri dish to give a depth of 3–4 mm. The paper
discs impregnated with the test compounds (500mg
mL21 in dimethylsulfoxide) were placed on the
solidified medium. The plates were refrigerated at
48C for 2 h and then incubated at 378C for 24 h. The
observed zones of inhibition (diameter) in mm are
presented in Table I.
Minimum inhibitory concentration. A series of glass tubes
containing different concentrations of the synthesized
compounds (1–500mg mL21 in dimethylsulfoxide)
with Mueller Hinton broth was inoculated with the
required amount of the inoculum to obtain a suspension
of microorganism, which contains 105 colony-forming
units per milliliter. One growth control tube was
prepared with the addition of the compound and one
blank tube was prepared without the addition of
microorganism. The tubes were incubated at 378C for
24 h. The turbidity produced in each tube was recorded
by using a UV- visible spectrometer. The minimum
inhibitory concentration (MIC- mg mL21) was
considered to be the lowest concentration, which
exhibited the same turbidity as the blank tube. The
observed MICs (mg mL21) are presented in Table II.
Results and discussion
Antimicrobial activity
1-Benzhydryl-piperazine derivatives 8(a– f) and
9(a–h) were synthesized and screened for their
efficacy as antimicrobials against various pathogens
Table I. Inhibition zone (diameter mm) of synthesized compounds against tested bacterial strains by paper disc diffusion method.
\
Gram-positive bacteria Gram-negative bacteria
Compound
B.cereus
11778
B.subtilis
6051
S. aureus
ATCC 25953
S. epidermids
ATCC 25212
P.aeruginosa
ATCC 2853
E.coli
ATCC
25922
P. vulgaris
ATCC 2853
S. typhi
ATCC 9484
8a 13 16 14 15 12 12 14 15
8b 14 13 12 10 15 16 12 13
8c 12 13 15 11 11 12 11 13
8d 27 28 26 27 22 21 22 25
8e 22 21 22 23 17 18 19 21
8f 12 13 14 11 16 17 12 14
9a 11 13 12 14 20 17 21 19
9b 23 20 21 22 22 21 23 20
9c 25 26 27 28 26 27 26 28
9d 20 21 20 19 19 16 20 17
9e 27 28 27 23 30 31 29 30
9f 29 27 26 30 29 26 28 28
9 g 20 19 20 18 23 21 24 20
9h 26 25 28 29 27 25 26 26
Streptomycin 24 21 22 23 22 20 23 22
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in vitro by paper disc diffusion and micro dilution
methods. Streptomycin was used as a standard against
both Gram-positive and Gram-negative bacteria. The
results are shown in Tables I and II.
Piperazine analogues are known to have antibacter-
ial activity [20,21]. Aromatic groups such as diphenyl
methyl group attached to piperazine help in improving
antibacterial activity of piperazine class of molecules
by increasing lipophilicity as supported by our
previous study [22]. At the same time, heterocyclic
sulfonamides and carboxamides are reported to
show antibacterial activity. Therefore in the present
work 1-benzhydryl-piperazine sulfonamides/carboxa-
mides derivatives are synthesised and screened for
antibacterial activity.
In general, the synthesized compounds showed
significant, moderate and less active inhibitory activity
against pathogenic bacterial strains. Among sulfona-
mides 8(a– f), compounds 8d and 8e showed
significant inhibitory activity against Gram-positive
(zone of inhibition 26–28 mm, 21–23 mm respect-
ively) and Gram-negative (zone of inhibition
21–25 mm, 17–20 mm respectively) bacteria. Com-
pounds 8a and 8f showed moderate activity with the
zone of inhibition in the range of 12–16 mm, 11–
17 mm respectively. Compounds 8b and 8c shows less
activity with the zone of inhibition in the range of 10–
16 mm, 11–15 mm respectively. From the results
obtained, it reveals that the presence of electron
withdrawing groups (chloro in 8d and 8e) in the
sulfonyl phenyl ring might be the reason for the
significant inhibitory activity. In the presence of
electron donating groups (tertiary butyl in 8f)
significant inhibition was not found. Compounds 8d
and 8e showed observable antibacterial activity at the
lower concentration of 72mg/mL and 66mg/mL against
Gram-negative bacteria P. aeruginosa ATCC 2853.
Generally in benzamide series 9(a–h), compounds
9c, 9e, 9f and 9h showed significant inhibitory activity
in the order 9h . 9c . 9e > 9f against Gram-positive
(zone of inhibition 26–30 mm, 25–29 mm, 25–28 mm
and 23–28 mm respectively) and Gram-negative (zone
of inhibition 29–31 mm, 20–29 mm, 26–28 mm and
26–27 mm respectively) bacteria. Compounds 9b, 9d,
9 g showed moderate activity with the zone of
inhibition in the range of 22–24 mm, 22–25 mm,
and 24–29 mm respectively, where as the compound
9a shows the less inhibitory activity.
From the results obtained, structure activity
relationship can be drawn for sulfonamide series
8(a–f). In this connection different electron donating
or withdrawing groups attached to phenyl ring as
substituents linked to sulfonyl group are studied for
antibacterial efficacy. Upon introduction of the nitro
group at the positions-2,-3 and -4 of the phenyl ring,
the 2-NO2 produces an enhanced activity probably by
an ortho effect compared to the meta and para
positions, indicating the positional requirement of
nitro group on phenyl ring for enhanced activity in
case of sulfonamide series 8(a–f). Whereas the
compound 8d exhibited better activity against both
gram positive and gram negative bacteria which has
two electron withdrawing chloro groups at position-2
and -5 compared to 8e which has only one chloro
group at the 4-position. Compound 8f showed
moderate activity against both gram positive and
gram negative bacteria might be due to the presence of
electron releasing tertiary butyl group.
In carboxamide series 9(a–h), compound 9 h
having a nitro groups in positions-3 and -5 produces
Table II. Minimum inhibitory concentration (MIC) in mg/mL of synthesized compounds against tested bacterial strains by micro dilution
method.
Gram-positive bacteria Gram-negative bacteria
Compound
B.cereus
11778
B.subtilis
6051
S. aureus
ATCC 25953
S. epidermids
ATCC 25212
P.aeruginosa
ATCC 2853
E.coli
ATCC
25922
P. vulgaris
ATCC 2853
S. typhi
ATCC 9484
8a 120 125 123 130 132 137 135 136
8b 132 130 135 131 144 110 135 140
8c 103 105 108 110 140 138 128 132
8d 80 85 86 79 72 80 82 73
8e 93 98 100 105 66 67 68 70
8f 144 120 123 150 85 82 73 74
9a 123 120 132 133 77 75 76 78
9b 95 96 98 99 82 85 83 88
9c 84 80 85 90 45 60 53 28
9d 64 65 68 70 96 98 80 17
9e 59 63 65 68 106 107 109 130
9f 43 48 49 60 79 78 79 28
9 g 60 63 68 65 142 165 130 128
9h 50 55 60 53 131 163 114 131
Streptomycin 157 210 234 134 154 178 147 195
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good activity than other compounds in the series
9(a-h). Introduction of chloro groups in 9e exhibits
better activity against both gram positive and gram
negative bacteria and fluoro groups in 9f produces
better activity against gram negative than gram
positive bacteria. Similarly in the presence of bromo
in 9d and methoxy group in 9 g showed moderate
activity where as in the presence of tertiary butyl
group in 9a produces minimal activity.
As the electron negativity increases, the inhibition
also increases as we observed from the derivatives 9c,
9e, 9f and 9h. Significant inhibition was not found in
the presence of electron donating groups in the amide
ring. Compound 9 h is most potent among the
benzamide series 9(a–h), showed observable anti-
bacterial activity against B. cereus 11778 at 43mg/mL,
B. substilis 6021 at 48mg/mL, S. aureus ATCC 25953
at 49mg/mL and S. epidermis 25212 at 60mg/mL. The
structures of the potent antibacterials are summarised
in Figure 1.
The structural correlation of the synthesized
compounds reveals that, keeping the same substitu-
ents at the same position on the phenyl ring of both the
sulfonamide and benzamide series (8e, 9b) and (8f,
9a) the sulfonamides show relatively significant
antibacterial activity. Another structural correlation
of the synthesized compounds is that, changing the
substituents on the phenyl ring in the same position
(8c, 9b) and (8b, 9 g), the carboxamides showed
relatively significant antibacterial activity. This
emphasises that, the nature of the functional linkage
(-SO2 - or –CO-NH-) influences the antibacterial
activity. Finally, the above two structural correlation
studies reveal that both nucleus and substituents are
responsible for the antibacterial activity.
Conclusion
In conclusion, a series of novel 1-benzhydryl-
piperazine derivatives 8(a–f) and 9(a–h) were
synthesized in good yield and their antimicrobial
activities were evaluated. Compounds 8d, 8e, 9c, 9e,
9f and 9h demonstrated potent inhibition against all
the strains tested. The two structural correlation
studies reveal that, both linkage and substituents on
phenyl ring are responsible for the antibacterial
activity of these class of agents. Further synthesis of
novel 1-benzhydryl-piperazine derivatives by changing
the functional group on the basic scaffold to improve
the antimicrobial activity is in progress in our
laboratory.
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